Group 1 - Yunnan Baiyao has experienced a decline for four consecutive trading days, with a cumulative drop of -1.33% [1] - Yunnan Baiyao Group Co., Ltd. is recognized as a leading innovative representative among the time-honored Chinese brands, established in 1902 [1] - In the first quarter of this year, E Fund's HuShen 300 Pharmaceutical ETF, one of Yunnan Baiyao's top ten shareholders, reduced its holdings [1] Group 2 - The year-to-date return for Yunnan Baiyao is 2.19%, ranking 1717 out of 3321 in its category [1][2] - The performance over the past week shows a decline of -0.22%, while the monthly performance is down -1.26% [2] - The fund manager of E Fund's HuShen 300 Pharmaceutical ETF is Yu Haiyan, who has extensive experience in the investment field [4][5]
云南白药连跌4天,易方达基金旗下1只基金位列前十大股东